Profits at Johnson & Johnson's Cork facility decrease by 35%

Revenues at the main Irish arm of the pharmaceutical giant fell by 2%, from €11.6bn to €11.39bn, last year

During the year, Janssen paid a dividend of €5.9bn to parent firm Janssen R&D Ireland Unlimited Company.

Pre-tax profits at the main Irish arm of pharmaceutical giant Johnson & Johnson declined last year by 35% to €4.47bn.

Accounts filed by Janssen Sciences Ireland UC show that profits decreased as revenues dipped by 2%, from €11.6bn to €11.39bn.